electroCore to Announce Fourth Quarter and Year Ended December 31, 2018 Financial Results on Wednesday, March 27

NEXT STORY
FDA approves Roche’s Tecentriq in combination with chemotherapy for the initial treatment of adults with extensive-stage small cell lung cancer
PREV STORY
Evolus Reports Fourth Quarter and Full Year 2018 Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

CFN Media’s Exclusive Interview with Pascal Biosciences

SEATTLE, Nov. 08, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – CFN Media Group (“CFN ...

author_avatar
NASDAQ Market News

UroGen Pharma to Present at the 36th Annual J.P. Morgan Healthcare Conference

RA’ANANA, Israel and NEW YORK, Jan. 02, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. ...

author_avatar
NASDAQ Market News

argenx reports first quarter 2017 financial results and provides business update

2 May 2017 Breda, the Netherlands/Ghent, Belgium argenx (Euronext Brussels: ARGX), a clinical-stage biotechnology ...

author_avatar
NASDAQ Market News